Moreover, in line with our in vitro results, hUC-MSCs also reduced the activation of NF-κB (Supplementary Fig. 2j) and interrupted pro-inflammatory cytokine release (Fig. 2f) in NMO mice. This evidence concerns the gene NFKB1 and neuromyelitis optica.